Eyepoint vs Therapeuticsmd
Eyepoint is the larger business, with $31.4m of revenue in fiscal 2025 against $3.0m for Therapeuticsmd (10.4 times as much). Therapeuticsmd grew faster (71.6% against -27.5%). Therapeuticsmd kept more of each dollar of sales as profit: a net margin of -18.8% against -739.4%. Eyepoint carries less debt relative to equity (0.0% against 0.0%).
| Latest fiscal year | EyepointEYPT, 2025 | TherapeuticsmdTXMD, 2025 |
|---|---|---|
| Revenue | $31.4m | $3.0m |
| Revenue growth | -27.5% | 71.6% |
| Net income | −$232m | −$569,000 |
| Operating margin | -776.0% | -145.3% |
| Net margin | -739.4% | -18.8% |
| Return on equity | -72.2% | -2.1% |
| Free cash flow | −$243m | $2.5m |
| Cash | $102m | $7.5m |
| Total debt | $0 | $0 |
| Debt to equity | 0.0% | 0.0% |
| Dividend per share | — | — |
| Dividend yield | — | — |
| Share buybacks | — | — |
| Employees | 214 | — |
| Market value | $32.9m | $20.7m |
| Price vs our value range | — | — |
| Moat score | 9 (Weak) | 22 (Weak) |
| Insider trades, 12 months | 2 buys, 11 sales | 1 buys, 0 sales |